Clinical trial of hypofractionation radiotherapy for early stage breast cancer after breast conserving surgery

ZHAO Shuhong,WANG Hong,ZHANG Runli,HOU Dongxiang,MA Changuo,ZHANG Xianbin

DOI: https://doi.org/10.3969/j.issn.1673-7210.2013.24.005

2013-01-01

Abstract:Objective To investigate the efficacy,cosmetic outcome and adverse reaction of hypofractionation radio therapy for early stage breast cancer after breast conserving surgery.Methods A total of 69 patients with early stage breast cancer after breast conserving surgery in People's Hospital of Shaanxi Province from 2006 to 2009 were includ ed.36 patients(HF group) were received whole-breast radiation to 42.56 Gy in 16 fractions followed by tumor bed boost of 7.98 Gy in 3 fractions;33 patients(CF group) were received whole-breast radiation to 50 Gy in 25 fractions followed by tumor bed boost of 10 Gy in 5 fractions.Kaplan-Meier of SPSS 16.0 was used to calculate local recur rence rates and the survival rates,the differences were compared by Log-rank test.Chi-square test was used to com pared the differences of the clinical characteristics,cosmetic outcome and toxicity between the two groups.Results The median follow-up time was 61 months,the follow-up rate was 100%.The 5-year overall survival rates were 100% in both groups.The local recurrence in HF and CF group was 0.0%,3.0% respectively(χ2=0.28,P=0.600).The incidence of grade 1 acute skin toxicity developed in CF and HF group was 55.6% and 51.5% respectively(χ2=0.11,P=0.737).Grade 1 late skin and subcutaneous tissue toxicity developed in HF and CF groups was 13.9% and 9.1% re spectively(χ2=0.06,P=0.806).Grade 1 neutropenia occurred in HF and CF groups was 8.3% and 12.1% respectively(χ2=0.02,P =0.903).The 1-,3-,5-year excellent and good rates of cosmetic outcomes of patients in HF and CF groups were 85.7% and 84.8%(χ2=0.01,P=0.920);88.2% and 87.1%(χ2=0.02,P=0.889);87.1% and 88.0%(χ2= 0.01,P =0.919).Conclusion Hypofractionation radiotherapy provides similar results to conventional radiotherapy in survival rate cosmetic outcome and toxicity.